pdgf bb (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
94
Structured Review
R&D Systems
pdgf bb
Pdgf Bb, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 61 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pdgf+bb/Mouse%2FRat+PDGF-BB+Quantikine+ELISA+Kit/pmc12859453-603-9-10
Average 94 stars, based on 61 article reviews
Pdgf Bb, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 61 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pdgf+bb/Mouse%2FRat+PDGF-BB+Quantikine+ELISA+Kit/pmc12859453-603-9-10
Average 94 stars, based on 61 article reviews
pdgf bb - by Bioz Stars,
2026-10
94/100 stars
Images
1) Product Images from "Sulfated polysaccharide prevents senescent adipocyte-driven osteonecrosis by stem cell fate reprogramming"
Article Title: Sulfated polysaccharide prevents senescent adipocyte-driven osteonecrosis by stem cell fate reprogramming
Journal: Bioactive Materials
doi: 10.1016/j.bioactmat.2025.11.039
Figure Legend Snippet: Continuous intraosseous administration of SCS prevents glucocorticoid-induced bone degeneration. ( A ) Schematic illustration of the glucocorticoid (GC; MPS)-induced bone deterioration and intraosseous SCS treatment. ( B-D ) Representative H&E staining images of the femur at 6 weeks (B). Magnified views of the cortical bone and trabecular bone in the marrow cavity are shown on the right. Solid arrows indicate normal osteocytes, while hollow arrows indicate empty osteocyte lacunae. Quantification of empty lacunae ratios in cortical bone (C) and trabecular bone (D). n = 6 biological replicates. (Scale bars, 500 μm and 25 μm) ( E-H ) Representative immunofluorescence staining of OPN + mature osteoblasts, osteolectin + osteoprogenitors, and VE-cadherin + endothelial cells (ECs) in femur at 6 weeks (E), and corresponding quantifications (F–H). n = 6 biological replicates. (Scale bars, 100 μm and 20 μm) ( I and J ) Representative flow cytometry plots of capillary subtypes in the femur (I), with quantification of CD45 − Ter119 − CD31 hi Emcn hi ECs (J). n = 6 biological replicates. ( K and L ) Flow cytometry plots showing Sca-1 hi CD31 hi arteriolar ECs (K), and corresponding quantification (L). n = 6 biological replicates. ( M and N ) Representative micro-CT 3D images of the femur (M). Quantitative analysis of percent bone volume (BV/TV) (N). n = 6 biological replicates. (Scale bars, 1.5 mm, 600 μm and 545 μm) ( O and P ) ELISA analysis of VEGF (O) and PDGF-BB (P) levels in bone marrow supernatant and peripheral serum from PBS- and SCS-treated groups at week 6. n = 6 biological replicates. ( Q ) ELISA quantification of the osteogenic factor osteocalcin in peripheral serum at week 6. n = 6 biological replicates. Data are presented as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001; ns, not significant. Statistical significance was determined using one-way ANOVA with Tukey's post hoc test ( C, D, F, G, H, J, L, N, O, P and Q ).
Techniques Used: Staining, Immunofluorescence, Flow Cytometry, Micro-CT, Enzyme-linked Immunosorbent Assay
Figure Legend Snippet: SCS targets downstream senescent lineage commitment of bone marrow MSCs to mitigate GC-induced bone deterioration. ( A ) Schematic diagram illustrating the experimental design: CD45 − Ter119 − CD31 − LepR + MSCs isolated from mice co-treated with SCS and MPS for 7 days were subjected to in vitro lineage-competitive differentiation, followed by DEX-induced senescence in lineage-mixed cells. These cells were then adoptively transplanted into healthy bone marrow cavity to assess bone deterioration development. ( B ) Representative H&E-stained images of the femur 12 weeks after adoptive transfer. PBS-DEX group: LepR + MSCs from PBS and MPS co-treated mice subjected to in vitro lineage differentiation and DEX-induced senescence, followed by transplantation. SCS-DEX group: LepR + MSCs from SCS and MPS co-treated mice processed similarly. PBS group: solvent control without cell transplantation. Solid arrows indicate intact osteocytes; hollow arrows indicate empty lacunae. (Scale bars, 250 μm and 25 μm) ( C – E ) Quantitative analysis of marrow hypertrophic adipocyte diameter (C), proportion of empty osteocyte lacunae in trabecular bone (D), and adipocyte number (E) in the metaphysis 12 weeks post-transplantation. n = 19 biological replicates (C), n = 6 biological replicates (D), n = 8 biological replicates (E). ( F ) Quantification of empty lacunae in epiphysis at 12 weeks post-transplantation. n = 6 biological replicates. ( G – I ) Representative flow cytometry plots of capillary ECs subtypes in the femur at 12 weeks (G), with quantification of CD45 − Ter119 − CD31 hi Emcn hi ECs (H) and CD45 − Ter119 − CD31 lo Emcn lo ECs (I). n = 6 biological replicates. ( J and K ) Representative flow cytometry plots (J) and corresponding quantification (K) of CD45 − Ter119 − Sca-1 hi CD31 hi arteriolar ECs in the femur at 12 weeks post-transplantation. n = 6 biological replicates. ( L ) Representative micro-CT images of the femur at 12 weeks post-transplantation across different treatment groups. (Scale bars, 1.5 mm and 500 μm) ( M – P ) Quantitative analysis of bone parameters in the metaphysis: bone mineral density (BMD) (M), percent bone volume (BV/TV) (N), trabecular separation (Tb.Sp) (O), and trabecular number (Tb.N) (P). n = 6 biological replicates. ( Q ) Serum ELISA analysis of the osteogenic marker osteocalcin at 12 weeks post-transplantation. n = 6 biological replicates. ( R and S ) ELISA analysis of PDGF-BB (R) and VEGF (S) in both bone marrow supernatant and peripheral serum at 12 weeks post-transplantation. n = 6 biological replicates. Data are presented as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001; ns, not significant. Statistical significance was determined using one-way ANOVA with Tukey's post hoc test ( C, D, E, F, H, I, K, M, N, O, P, Q, R and S ).
Techniques Used: Isolation, In Vitro, Staining, Adoptive Transfer Assay, Transplantation Assay, Solvent, Control, Flow Cytometry, Micro-CT, Enzyme-linked Immunosorbent Assay, Marker
Related Articles
Incubation:Article Title: Kindlin‐2 Deletion in Mural Cells Leads to Vascular Instability Article Snippet: To assess integrin activation, vSMCs were pretreated with mouse or human Seroblock (BD Biosciences, San Jose, CA, USA) for 15 min at RT in HBSS buffer containing 0.1% BSA, 0.5 mM CaCl 2 and MgCl 2 . .. Next, vSMCs were incubated with mAbs to activation‐dependent epitopes on the β 1 integrin subunit: mouse vSMCs: rat anti‐CD29 (clone 9EG7) [ ] followed by goat anti‐rat IgG‐PE; human vSMCs: anti‐CD29‐PE (clone HUTS‐21) (BD Biosciences, San Jose, CA, USA) [ , ] and with mAbs to total β 1 ‐integrin subunit mouse vSMCs: anti‐CD29‐FITC (clone MB1.2) (Millipore‐Sigma, Cuyahoga Heights, OH, USA); human vSMCs: anti‐CD29‐PE (clone MAR4) (BD Biosciences, San Jose, CA, USA) in the absence or presence of Article Title: Hyperglycemia-Reduced Platelet-Derived Growth Factor–BB Expression Impairs Corneal Wound Healing in Diabetic Mice Article Snippet: .. Cells were seeded into 96-well plates at 5,000 cells/well and incubated for 24 hours under the following conditions: Article Title: Kindlin‐2 Deletion in Mural Cells Leads to Vascular Instability Article Snippet: To assess integrin activation, vSMCs were pretreated with mouse or human Seroblock (BD Biosciences, San Jose, CA, USA) for 15 min at RT in HBSS buffer containing 0.1% BSA, 0.5 mM CaCl2 and MgCl2. .. Next, vSMCs were incubated with mAbs to activation- dependent epitopes on the β1 integrin subunit: mouse vSMCs: rat anti- CD29 (clone 9EG7) [39] followed by goat antirat IgG- PE; human vSMCs: anti- CD29- PE (clone HUTS- 21) (BD Biosciences, San Jose, CA, USA) [40, 41] and with mAbs to total β1- integrin subunit mouse vSMCs: anti- CD29- FITC (clone MB1.2) (Millipore- Sigma, Cuyahoga Heights, OH, USA); human vSMCs: anti- CD29- PE (clone MAR4) (BD Biosciences, San Jose, CA, USA) in the absence or presence of Activation Assay:Article Title: Kindlin‐2 Deletion in Mural Cells Leads to Vascular Instability Article Snippet: To assess integrin activation, vSMCs were pretreated with mouse or human Seroblock (BD Biosciences, San Jose, CA, USA) for 15 min at RT in HBSS buffer containing 0.1% BSA, 0.5 mM CaCl 2 and MgCl 2 . .. Next, vSMCs were incubated with mAbs to activation‐dependent epitopes on the β 1 integrin subunit: mouse vSMCs: rat anti‐CD29 (clone 9EG7) [ ] followed by goat anti‐rat IgG‐PE; human vSMCs: anti‐CD29‐PE (clone HUTS‐21) (BD Biosciences, San Jose, CA, USA) [ , ] and with mAbs to total β 1 ‐integrin subunit mouse vSMCs: anti‐CD29‐FITC (clone MB1.2) (Millipore‐Sigma, Cuyahoga Heights, OH, USA); human vSMCs: anti‐CD29‐PE (clone MAR4) (BD Biosciences, San Jose, CA, USA) in the absence or presence of Article Title: Kindlin‐2 Deletion in Mural Cells Leads to Vascular Instability Article Snippet: To assess integrin activation, vSMCs were pretreated with mouse or human Seroblock (BD Biosciences, San Jose, CA, USA) for 15 min at RT in HBSS buffer containing 0.1% BSA, 0.5 mM CaCl2 and MgCl2. .. Next, vSMCs were incubated with mAbs to activation- dependent epitopes on the β1 integrin subunit: mouse vSMCs: rat anti- CD29 (clone 9EG7) [39] followed by goat antirat IgG- PE; human vSMCs: anti- CD29- PE (clone HUTS- 21) (BD Biosciences, San Jose, CA, USA) [40, 41] and with mAbs to total β1- integrin subunit mouse vSMCs: anti- CD29- FITC (clone MB1.2) (Millipore- Sigma, Cuyahoga Heights, OH, USA); human vSMCs: anti- CD29- PE (clone MAR4) (BD Biosciences, San Jose, CA, USA) in the absence or presence of Binding Assay:Article Title: Kindlin‐2 Deletion in Mural Cells Leads to Vascular Instability Article Snippet: To assess integrin activation, vSMCs were pretreated with mouse or human Seroblock (BD Biosciences, San Jose, CA, USA) for 15 min at RT in HBSS buffer containing 0.1% BSA, 0.5 mM CaCl 2 and MgCl 2 . .. Next, vSMCs were incubated with mAbs to activation‐dependent epitopes on the β 1 integrin subunit: mouse vSMCs: rat anti‐CD29 (clone 9EG7) [ ] followed by goat anti‐rat IgG‐PE; human vSMCs: anti‐CD29‐PE (clone HUTS‐21) (BD Biosciences, San Jose, CA, USA) [ , ] and with mAbs to total β 1 ‐integrin subunit mouse vSMCs: anti‐CD29‐FITC (clone MB1.2) (Millipore‐Sigma, Cuyahoga Heights, OH, USA); human vSMCs: anti‐CD29‐PE (clone MAR4) (BD Biosciences, San Jose, CA, USA) in the absence or presence of Article Title: Kindlin‐2 Deletion in Mural Cells Leads to Vascular Instability Article Snippet: To assess integrin activation, vSMCs were pretreated with mouse or human Seroblock (BD Biosciences, San Jose, CA, USA) for 15 min at RT in HBSS buffer containing 0.1% BSA, 0.5 mM CaCl2 and MgCl2. .. Next, vSMCs were incubated with mAbs to activation- dependent epitopes on the β1 integrin subunit: mouse vSMCs: rat anti- CD29 (clone 9EG7) [39] followed by goat antirat IgG- PE; human vSMCs: anti- CD29- PE (clone HUTS- 21) (BD Biosciences, San Jose, CA, USA) [40, 41] and with mAbs to total β1- integrin subunit mouse vSMCs: anti- CD29- FITC (clone MB1.2) (Millipore- Sigma, Cuyahoga Heights, OH, USA); human vSMCs: anti- CD29- PE (clone MAR4) (BD Biosciences, San Jose, CA, USA) in the absence or presence of Expressing:Article Title: Kindlin‐2 Deletion in Mural Cells Leads to Vascular Instability Article Snippet: To assess integrin activation, vSMCs were pretreated with mouse or human Seroblock (BD Biosciences, San Jose, CA, USA) for 15 min at RT in HBSS buffer containing 0.1% BSA, 0.5 mM CaCl 2 and MgCl 2 . .. Next, vSMCs were incubated with mAbs to activation‐dependent epitopes on the β 1 integrin subunit: mouse vSMCs: rat anti‐CD29 (clone 9EG7) [ ] followed by goat anti‐rat IgG‐PE; human vSMCs: anti‐CD29‐PE (clone HUTS‐21) (BD Biosciences, San Jose, CA, USA) [ , ] and with mAbs to total β 1 ‐integrin subunit mouse vSMCs: anti‐CD29‐FITC (clone MB1.2) (Millipore‐Sigma, Cuyahoga Heights, OH, USA); human vSMCs: anti‐CD29‐PE (clone MAR4) (BD Biosciences, San Jose, CA, USA) in the absence or presence of Article Title: Kindlin‐2 Deletion in Mural Cells Leads to Vascular Instability Article Snippet: To assess integrin activation, vSMCs were pretreated with mouse or human Seroblock (BD Biosciences, San Jose, CA, USA) for 15 min at RT in HBSS buffer containing 0.1% BSA, 0.5 mM CaCl2 and MgCl2. .. Next, vSMCs were incubated with mAbs to activation- dependent epitopes on the β1 integrin subunit: mouse vSMCs: rat anti- CD29 (clone 9EG7) [39] followed by goat antirat IgG- PE; human vSMCs: anti- CD29- PE (clone HUTS- 21) (BD Biosciences, San Jose, CA, USA) [40, 41] and with mAbs to total β1- integrin subunit mouse vSMCs: anti- CD29- FITC (clone MB1.2) (Millipore- Sigma, Cuyahoga Heights, OH, USA); human vSMCs: anti- CD29- PE (clone MAR4) (BD Biosciences, San Jose, CA, USA) in the absence or presence of Small Interfering RNA:Article Title: Hyperglycemia-Reduced Platelet-Derived Growth Factor–BB Expression Impairs Corneal Wound Healing in Diabetic Mice Article Snippet: .. Cells were seeded into 96-well plates at 5,000 cells/well and incubated for 24 hours under the following conditions: Control:Article Title: Hyperglycemia-Reduced Platelet-Derived Growth Factor–BB Expression Impairs Corneal Wound Healing in Diabetic Mice Article Snippet: .. Cells were seeded into 96-well plates at 5,000 cells/well and incubated for 24 hours under the following conditions: Article Title: Ginsenoside compound K exerts osteoprotective effects by suppressing osteoclastogenesis and promoting preosteoclast PDGF-BB-induced angiogenesis via targeting CSF1R. Article Snippet: We previously found that oral administration of Panax notoginseng saponins (PNS) alleviated bone loss in ovariectomy(OVX)-induced osteoporotic mice.. However, the specific active component responsible for this effect and its underlying mechanism remained unclear.. Ginsenoside compound K (CK), one of the main active components of PNS, may serve as a promising therapeutic agent for osteoporosis. Article Title: In Vitro Enhanced Performance of Human Platelet Lysate Gel Integrated with Mesoporous Silica Nanoparticle/Carboxymethyl Chitosan Composite Hydrogel: Structural Stability and Biological Activities for Chronic Wound Healing Article Snippet: .. To unequivocally determine the role of Recombinant:Article Title: Durotaxis is a driver and potential therapeutic target in lung fibrosis and metastatic pancreatic cancer Article Snippet: F-actin and nuclei were stained with Alexa Fluor 546– phalloidin and 4′,6-diamidino-2-phenylindole (DAPI) (Invitrogen), respectively. .. Antibody dilutions were prepared according to the manufacturer's guidelines Mouse and human recombinant TGF-β1 and Enzyme-linked Immunosorbent Assay:Article Title: Sulfated polysaccharide prevents senescent adipocyte-driven osteonecrosis by stem cell fate reprogramming Article Snippet: .. Levels of angiogenesis-associated factors, including VEGF (Neobioscience, EMC103.96) and Migration:Article Title: In Vitro Enhanced Performance of Human Platelet Lysate Gel Integrated with Mesoporous Silica Nanoparticle/Carboxymethyl Chitosan Composite Hydrogel: Structural Stability and Biological Activities for Chronic Wound Healing Article Snippet: .. To unequivocally determine the role of Activity Assay:Article Title: In Vitro Enhanced Performance of Human Platelet Lysate Gel Integrated with Mesoporous Silica Nanoparticle/Carboxymethyl Chitosan Composite Hydrogel: Structural Stability and Biological Activities for Chronic Wound Healing Article Snippet: .. To unequivocally determine the role of Negative Control:Article Title: In Vitro Enhanced Performance of Human Platelet Lysate Gel Integrated with Mesoporous Silica Nanoparticle/Carboxymethyl Chitosan Composite Hydrogel: Structural Stability and Biological Activities for Chronic Wound Healing Article Snippet: .. To unequivocally determine the role of |
